Why the study?
What are the muscular effects and molecular/genetic basis of statin-induced myopathy in elderly females?
What are the muscular effects and molecular/genetic basis of statin-induced myopathy in elderly females?
This review highlights the specific vulnerability of elderly women to statin-induced myopathy and emphasizes the need for strategies to reduce its incidence to improve compliance and outcomes.
May warrant closer myopathy monitoring in elderly women on statins; leaves open need for prospective confirmation and prevention trials.
Statins have demonstrated substantial benefits in supporting cardiovascular health. Older individuals are more likely to experience the well-known muscle-related side effects of statins compared with younger individuals. Elderly females may be especially vulnerable to statin-related muscle disorder. This review will collate and discuss statin-related muscular effects, examine their molecular and genetic basis, and how these apply specifically to elderly women. Developing strategies to reduce the incidence of statin-induced myopathy in older adult women could contribute to a significant reduction in the overall incidence of statin-induced muscle disorder in this vulnerable group of patients. Reducing statin-related muscle disorder would likely improve overall patient compliance, thereby leading to an increase in improved short- and long-term outcomes associated with appropriate use of statins.
No takes yet. Share an insight, caveat, or question.
Schneider et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: